-
Signature
-
/s/ Gregory S. Moss, Attorney-in-Fact
-
Issuer symbol
-
EVMN on NYSE
-
Transactions as of
-
05 Nov 2025
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
07 Nov 2025, 16:15:14 UTC
Quoteable Key Fact
"Jeegar Pravinkumar Patel filed Form 4 for Evommune, Inc. on 07 Nov 2025."
Quick Takeaways
- This page summarizes Jeegar Pravinkumar Patel's Form 4 filing for Evommune, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 07 Nov 2025, 16:15.
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Patel Jeegar Pravinkumar |
Chief Scientific Officer |
C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO |
/s/ Gregory S. Moss, Attorney-in-Fact |
07 Nov 2025 |
0002092017 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EVMN |
Employee Stock Option (Right to Buy) |
Award |
$0 |
+179,619 |
|
$0.000000 |
179,619 |
05 Nov 2025 |
Common Stock |
179,619 |
$16.00 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: